Aperture Bio
Techstars '23Allston, US · 1 known investors
Aperture Bio develops technologies to translate human tumor biology in order to reduce risk in preclinical drug development.
AI & Machine LearningBiotechHealthtech
Investors · 1
In the news
- Aperture Bio - 2026 Company Profile, Funding & Competitors - Tracxntracxn.com · 2024